Back to results
US 5,668,181 AGranted
Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression
AssigneesTeva Pharmaceutical Industries Ltd., Techion Research and Development Foundation Ltd.
InventorsMoussa B. H. Youdim, John P. M. Finberg, Ruth Levy, Jeffrey Sterling, David Lerner, Tirtsah Berger-Paskin, Haim Yellin
Life of this patent
Estimating the term…
Abstract
This invention relates to the use of R(+)-N-propargyl-1-aminoindan.
Claims7
A method of treating a subject for depression, which comprises administering to the subject a pharmaceutical composition consisting essentially of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof in an amount effective to treat the subject and a carrier.
Dependencies are inferred from the claim text.